keyword
Keywords oral and topical antibiotics i...

oral and topical antibiotics in impetigo

https://read.qxmd.com/read/37100956/topical-nanotherapeutics-for-treating-mrsa-associated-skin-and-soft-tissue-infection-sstis
#1
REVIEW
Sriravali Karnam, Anil B Jindal, Charu Agnihotri, Bhim Pratap Singh, Atish T Paul
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) imposes a major challenge for the treatment of infectious diseases with existing antibiotics. MRSA associated with superficial skin and soft tissue infections (SSTIs) is one of them, affecting the skin's superficial layers, and it includes impetigo, folliculitis, cellulitis, furuncles, abscesses, surgical site infections, etc. The efficient care of superficial SSTIs caused by MRSA necessitates local administration of antibiotics, because oral antibiotics does not produce the required concentration at the local site...
April 26, 2023: AAPS PharmSciTech
https://read.qxmd.com/read/37023250/feasibility-study-for-randomised-control-trial-for-topical-treatment-of-impetigo-in-australian-general-practice
#2
JOURNAL ARTICLE
Clare Heal
Context Impetigo affects millions of children worldwide. Most guidelines recommend antibiotics as first-line treatment however topical antiseptics present a potentially valuable, understudied, antibiotic-sparing treatment for mild impetigo. Objective We aimed to determine the feasibility of a randomized controlled trial (RCT) comparing efficacy of soft white paraffin (SWP), hydrogen peroxide (H2O2) and mupirocin for mild impetigo. Study Design The study was designed in keeping with the SPIRIT statement and designed in accordance with the CONSORT statement for pilot RCTs Setting, population studied Consecutive patients presenting with mild impetigo were recruited from two private general practices in North Queensland, Australia...
January 1, 2023: Annals of Family Medicine
https://read.qxmd.com/read/35795839/new-therapeutic-applications-of-ozenoxacin-in-superficial-skin-infections
#3
JOURNAL ARTICLE
Gema García Ron, María Villa Arranz
In recent years, the incidence of community- acquired methicillin-resistant S. aureus skin infections (CA-MARSA) has increased in pediatric population without associated risk factors. Ozenoxacin 10mg/g is a topical quinolone that has shown high activity on strains of S. aureus, S. pyogenes and other Gram-positive bacteria sensitive and resistant to methicillin, other quinolones, mupirocin and fusidic acid. Ozenoxacin 10mg/g cream was applied twice a day for 5 days in pediatric patients with superficial skin infections other than non-bullous impetigo where oral antibiotics were not needed...
June 16, 2022: Dermatology Reports
https://read.qxmd.com/read/34842831/feasibility-study-for-a-randomised-controlled-trial-for-the-topical-treatment-of-impetigo-in-australian-general-practice
#4
JOURNAL ARTICLE
Hilary Gorges, Leanne Hall, Clare Heal
Impetigo affects millions of children worldwide. Most guidelines recommend antibiotics as first-line treatment; however, topical antiseptics present a potentially valuable, understudied, antibiotic-sparing treatment for mild impetigo. We aimed to determine the feasibility of a randomised controlled trial (RCT) comparing efficacy of soft white paraffin (SWP), hydrogen peroxide (H2 O2 ) and mupirocin for mild impetigo. Participants were recruited from general practices and randomly assigned one of three treatments...
November 9, 2021: Tropical Medicine and Infectious Disease
https://read.qxmd.com/read/34053699/emerging-treatment-strategies-for-impetigo-in-endemic-and-nonendemic-settings-a-systematic-review
#5
REVIEW
Garima Gahlawat, Wubshet Tesfaye, Mary Bushell, Solomon Abrha, Gregory M Peterson, Cynthia Mathew, Mahipal Sinnollareddy, Faye McMillan, Indira Samarawickrema, Tom Calma, Aileen Y Chang, Daniel Engelman, Andrew Steer, Jackson Thomas
PURPOSE: Impetigo affects approximately 162 million children worldwide at any given time. Lack of consensus on the most effective treatment strategy for impetigo and increasing antibiotic resistance continue to drive research into newer and alternative treatment options. We conducted a systematic review to assess the effectiveness of new treatments for impetigo in endemic and nonendemic settings. METHODS: We searched PubMed, MEDLINE, CINAHL, Web of Science, and Embase via Scopus for studies that explored treatments for bullous, nonbullous, primary, and secondary impetigo published between August 1, 2011, and February 29, 2020...
June 2021: Clinical Therapeutics
https://read.qxmd.com/read/33538559/do-antimicrobial-resistance-patterns-matter-an-algorithm-for-the-treatment-of-patients-with-impetigo
#6
REVIEW
Lawrence A Schachner, Anneke Andriessen, Latanya T Benjamin, Cristina Claro, Lawrence F Eichenfield, Susanna Mr Esposito, Linda Keller, Leon Kircik, Pearl C Kwong, Catherine McCuaig
BACKGROUND: Impetigo, a highly contagious bacterial skin infection commonly occurring in young children, but adults may also be affected. The superficial skin infection is mainly caused by Staphylococcus aureus (S. aureus) and less frequently by Streptococcus pyogenes (S. pyogenes). Antimicrobial resistance has become a worldwide concern and needs to be addressed when selecting treatment for impetigo patients. An evidence-based impetigo treatment algorithm was developed to address the treatment of impetigo for pediatric and adult populations...
February 1, 2021: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/33333955/intolerable-burden-of-impetigo-in-endemic-settings-a-review-of-the-current-state-of-play-and-future-directions-for-alternative-treatments
#7
REVIEW
Solomon Abrha, Wubshet Tesfaye, Jackson Thomas
Impetigo (school sores) is a common superficial bacterial skin infection affecting around 162 million children worldwide, with the highest burden in Australian Aboriginal children. While impetigo itself is treatable, if left untreated, it can lead to life-threatening conditions, such as chronic heart and kidney diseases. Topical antibiotics are often considered the treatment of choice for impetigo, but the clinical efficacy of these treatments is declining at an alarming rate due to the rapid emergence and spread of resistant bacteria...
December 15, 2020: Antibiotics
https://read.qxmd.com/read/32550690/treatment-of-impetigo-in-the-pediatric-population-consensus-and-future-directions
#8
JOURNAL ARTICLE
Lawrence A Schachner, Antonio Torrelo, Ayman Grada, Giuseppe Micali, Pearl C Kwong, Gwenolyn B Scott, Latanya Benjamin, Mercedes E Gonzalez, Anneke Andriessen, Thomas Eberlein, Lawrence F Eichenfield
BACKGROUND: Impetigo is a common contagious superficial bacterial skin infection. Treatment of localized lesions can be achieved through topical antibiotics. Oral antibiotics are reserved for extensive disease. Increasing antimicrobial resistance to existing therapies have raised concerns. Antimicrobial stewardship, achieved through the responsible use of antibiotics, is an important measure to re-duce bacterial resistance. This review highlights treatment options for impetigo and shares consensus statements to help guide the management of impetigo in the pediatric population...
March 1, 2020: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/31630410/skin-infections-in-australian-aboriginal-children-a-narrative-review
#9
REVIEW
Lucy Davidson, Jessica Knight, Asha C Bowen
Impetigo, scabies, cellulitis and abscesses are common in Australian Aboriginal children. These conditions adversely affect wellbeing and are associated with serious long term sequelae, including invasive infection and post-infectious complications, such as acute post-streptococcal glomerulonephritis and acute rheumatic fever, which occurs at the highest documented rates in the world in remote Aboriginal communities. Observational research in remote communities in northern Australia has demonstrated a high concurrent burden of scabies and impetigo and their post-infectious complications...
March 2020: Medical Journal of Australia
https://read.qxmd.com/read/31540550/talking-skin-attitudes-and-practices-around-skin-infections-treatment-options-and-their-clinical-management-in-a-remote-region-in-western-australia
#10
JOURNAL ARTICLE
Ingrid Amgarth-Duff, David Hendrickx, Asha Bowen, Jonathan Carapetis, Robby Chibawe, Margaret Samson, Roz Walker
INTRODUCTION: Skin infections including scabies and impetigo have a high burden and cause significant morbidity in remote Aboriginal communities in Australia. Nevertheless, there is limited knowledge about community, healthcare practitioner and service provider perspectives on skin infections and treatment preferences. An increased understanding of their respective knowledge, attitudes and practices will contribute to improving healthcare seeking behaviour, improved diagnosis, treatment acceptability and quality of care within remote Aboriginal communities...
September 2019: Rural and Remote Health
https://read.qxmd.com/read/31334625/topical-ozenoxacin-cream-1-for-impetigo-a-review
#11
REVIEW
Lawrence Schachner, Anneke Andriessen, Neal Bhatia, Ayman Grada, Dillon Patele
Background: Impetigo, a bacterial infection that is highly contagious, involves the superficial skin. Topical treatment for impetigo includes amongst other bacitracin, gentamycin, mupirocin, retapamulin, and more recently, ozenoxacin 1% cream. For more severe conditions systemic antibiotics are prescribed and may be combined with a topical treatment. The current review explored the challenges in treating impetigo in pediatric and adult populations and examined the role of ozenoxacin 1% cream as a safe and effective treatment option...
July 1, 2019: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/30571809/-pemphigus-vulgaris-in-pediatrics-a-case-report
#12
JOURNAL ARTICLE
Ana Laura Casuriaga Lamboglia, Agustina Minut Gubitosi, Claudia Guebenlián Bakerdjian, Gustavo Giachetto Larraz
INTRODUCTION: pemphigus vulgaris is a serious and infrequent disease in children. Its timely diagnosis and treatment allows modifying its prognosis. The objective is to describe its clinical characteristics, and the diagnostic and therapeutic approach of this uncommon autoimmune blistering disease in children. CLINICAL CASE: 2-year-old male patient, previously healthy. He initially presented generalized dermatosis with maximum lesion areas at the umbilical region, limbs and genitals; characterized by blisters, some denuded, and of easy bleeding, without mucosal involvement nor fever...
October 2018: Revista Chilena de Pediatría
https://read.qxmd.com/read/30346521/impetigo-incidence-and-treatment-a-retrospective-study-of-dutch-routine-primary-care-data
#13
JOURNAL ARTICLE
Madelyn E N Loadsman, Theo J M Verheij, Alike W van der Velden
BACKGROUND: There is a lack of recently published data on impetigo presentation incidence and treatment practices in the routine Western European primary care setting. OBJECTIVES: To investigate impetigo incidence, treatments and recurrence in primary care in the Netherlands. METHODS: A retrospective, observational study. Electronic records of patients treated for impetigo in 2015 at 29 general practices in Utrecht and surrounds were reviewed...
July 31, 2019: Family Practice
https://read.qxmd.com/read/29063621/impetigo-a-need-for-new-therapies-in-a-world-of-increasing-antimicrobial-resistance
#14
JOURNAL ARTICLE
N M D'Cunha, G M Peterson, K E Baby, J Thomas
WHAT IS KNOWN AND OBJECTIVE: Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children. Antibiotics are the first-line treatment when multiple lesions exist, but with an increasing prevalence of antibiotic-resistant bacteria the successful management of impetigo in the future is an area of concern. COMMENT: Current treatment options that favour the use of oral antibiotic therapy are increasingly problematic...
February 2018: Journal of Clinical Pharmacy and Therapeutics
https://read.qxmd.com/read/28196318/common-skin-conditions-in-children-skin-infections
#15
REVIEW
Brian Z Rayala, Dean S Morrell
Skin infections account for a significant subset of dermatologic conditions of childhood. Common cutaneous viral infections in children include warts, molluscum contagiosum, hand-foot-and-mouth disease, and herpes simplex. Although viral infections are self-limited and often only mildly symptomatic, they can cause anxiety, embarrassment, and health care use. Recognition of their common and atypical presentations is necessary to differentiate them from other skin conditions of similar morphology. Impetigo, cellulitis, and abscess comprise the majority of childhood bacterial skin infections and are treated with topical or systemic antibiotics that cover group A Streptococcus and Staphylococcus aureus...
February 2017: FP Essentials
https://read.qxmd.com/read/25396674/a-randomized-double-blind-comparative-study-to-assess-the-safety-and-efficacy-of-topical-retapamulin-ointment-1-versus-oral-linezolid-in-the-treatment-of-secondarily-infected-traumatic-lesions-and-impetigo-due-to-methicillin-resistant-staphylococcus-aureus
#16
RANDOMIZED CONTROLLED TRIAL
Tonny Tanus, Nicole E Scangarella-Oman, Marybeth Dalessandro, Gang Li, John J Breton, John F Tomayko
OBJECTIVE: To evaluate the clinical and bacteriological efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of patients with secondarily infected traumatic lesions (SITLs; excluding abscesses) or impetigo due to methicillin-resistant Staphylococcus aureus (MRSA). DESIGN: A randomized, double-blind, double-dummy, multicenter, comparative study (NCT00852540). SETTING: Patients recruited from 36 study centers in the United States...
December 2014: Advances in Skin & Wound Care
https://read.qxmd.com/read/25250996/impetigo-diagnosis-and-treatment
#17
REVIEW
Holly Hartman-Adams, Christine Banvard, Gregory Juckett
Impetigo is the most common bacterial skin infection in children two to five years of age. There are two principal types: nonbullous (70% of cases) and bullous (30% of cases). Nonbullous impetigo, or impetigo contagiosa, is caused by Staphylococcus aureus or Streptococcus pyogenes, and is characterized by honey-colored crusts on the face and extremities. Impetigo primarily affects the skin or secondarily infects insect bites, eczema, or herpetic lesions. Bullous impetigo, which is caused exclusively by S. aureus, results in large, flaccid bullae and is more likely to affect intertriginous areas...
August 15, 2014: American Family Physician
https://read.qxmd.com/read/25172376/short-course-oral-co-trimoxazole-versus-intramuscular-benzathine-benzylpenicillin-for-impetigo-in-a-highly-endemic-region-an-open-label-randomised-controlled-non-inferiority-trial
#18
RANDOMIZED CONTROLLED TRIAL
Asha C Bowen, Steven Y C Tong, Ross M Andrews, Irene M O'Meara, Malcolm I McDonald, Mark D Chatfield, Bart J Currie, Jonathan R Carapetis
BACKGROUND: Impetigo affects more than 110 million children worldwide at any one time. The major burden of disease is in developing and tropical settings where topical antibiotics are impractical and lead to rapid emergence of antimicrobial resistance. Few trials of systemic antibiotics are available to guide management of extensive impetigo. As such, we aimed to compare short-course oral co-trimoxazole with standard treatment with intramuscular benzathine benzylpenicillin in children with impetigo in a highly endemic setting...
December 13, 2014: Lancet
https://read.qxmd.com/read/24957981/-superficial-skin-infections-and-bacterial-dermohypodermitis
#19
JOURNAL ARTICLE
M Lorrot, E Bourrat, C Doit, S Prot-Labarthe, S Dauger, A Faye, R Blondé, Y Gillet, E Grimprel, F Moulin, B Quinet, R Cohen, S Bonacorsi
Staphylococcus aureus and Streptococcus pyogenes are the two main bacteria involved in skin infections in children. Mild infections like limited impetigo and furonculosis should preferentially be treated by topical antibiotics (mupirocine or fucidic acid). Empiric antimicrobial therapy of dermohypodermitis consists in amoxicillin-clavulanate through oral route (80 mg/kg/d) or parenteral route (150 mg/kg amoxicillin per d. in 3-4 doses) for complicated features: risk factors of extension of the infection, sepsis or fast evolution...
August 2014: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie
https://read.qxmd.com/read/24823337/pediatric-burn-wound-impetigo-after-grafting
#20
JOURNAL ARTICLE
Kimberly Aikins, Narayan Prasad, Seema Menon, John G Harvey, Andrew J A Holland
Modern burn care techniques have reduced the risk of infection of the acute burn wound, resulting in more rapid healing and a lower incidence of graft loss. Secondary breakdown may still occur. The loss of epithelium in association with multifocal superficial abscesses and ulceration has been termed burns impetigo. This may result in considerable morbidity and require prolonged treatment. The events preceding development, the impact on the patient, and the ideal treatment appear unclear and poorly reported...
March 2015: Journal of Burn Care & Research: Official Publication of the American Burn Association
keyword
keyword
97696
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.